The intraday gains of innovative drugs and CRO concepts expanded. Nanmo Biotech rose 20 cm, and nearshore protein and pepsis rose more than 10%, both of which reached record highs. Previously, Cansino, Tenomebo, Kangchen Pharmaceutical, and Osecon had higher gains.

Zhitongcaijing · 2d ago
The intraday gains of innovative drugs and CRO concepts expanded. Nanmo Biotech rose 20 cm, and nearshore protein and pepsis rose more than 10%, both of which reached record highs. Previously, Cansino, Tenomebo, Kangchen Pharmaceutical, and Osecon had higher gains.